| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nicole L Baganz, Rebecca E Horton, Alfredo S Calderon, W Anthony Owens, Jaclyn L Munn, Lora T Watts, Nina Koldzic-Zivanovic, Nathaniel A Jeske, Wouter Koek, Glenn M Toney, Lynette C Daw. Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. vol 105. issue 48. 2009-01-05. PMID:19033200. |
a common serotonin (5-ht) transporter (5-htt/sert, slc6a4) polymorphism is believed to confer lower 5-htt expression in vivo and elevates risk for multiple mood disorders including anxiety, alcoholism, and major depression. |
2009-01-05 |
2023-08-12 |
mouse |
| Maria T G Perona, Shonna Waters, Frank Scott Hall, Ichiro Sora, Klaus-Peter Lesch, Dennis L Murphy, Marc Caron, George R Uh. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behavioural pharmacology. vol 19. issue 5-6. 2008-12-31. PMID:18690111. |
animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. |
2008-12-31 |
2023-08-12 |
mouse |
| Karen L Rega. Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review. The Journal of cardiovascular nursing. vol 23. issue 6. 2008-12-31. PMID:18953212. |
depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review. |
2008-12-31 |
2023-08-12 |
Not clear |
| Eleanor L Olvey, Grant H Skrepne. The cost-effectiveness of sertraline in the treatment of depression. Expert opinion on pharmacotherapy. vol 9. issue 14. 2008-12-29. PMID:18778187. |
the selective serotonin re-uptake inhibitors (ssris) represent the most commonly utilized drug class for the treatment of depression; sertraline is the most prescribed single agent and received generic drug approval in 2006. |
2008-12-29 |
2023-08-12 |
Not clear |
| Jun'ichi Semba, Maki Wakut. Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion. Psychiatry and clinical neurosciences. vol 62. issue 4. 2008-12-23. PMID:18778441. |
to investigate the neuronal mechanisms of the precipitation of depression during smoking cessation, an animal model of nicotine withdrawal was used, and the expression of serotonin transporter (5htt), abnormality of which is implicated in the pathogenesis of depression, was investigated. |
2008-12-23 |
2023-08-12 |
rat |
| Thomas C Rosenthal, Barbara A Majeroni, Richard Pretorius, Khalid Mali. Fatigue: an overview. American family physician. vol 78. issue 10. 2008-12-16. PMID:19035066. |
selective serotonin reuptake inhibitors, such as fluoxetine, paroxetine, or sertraline, may improve energy in patients with depression. |
2008-12-16 |
2023-08-12 |
Not clear |
| Subhash M Nadgir, Manish Malviy. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain. Neurochemical research. vol 33. issue 11. 2008-12-12. PMID:18437564. |
serotonin transporters (sert) have been implicated in the etiology of depression and drugs acting on sert can be effective in treating depression. |
2008-12-12 |
2023-08-12 |
rat |
| Eric J Lenze, Michelle Shardell, Robert E Ferrell, Denise Orwig, Janet Yu-Yahiro, William Hawkes, Lisa Fredman, Ram Miller, Jay Magazine. Association of serotonin-1A and 2A receptor promoter polymorphisms with depressive symptoms and functional recovery in elderly persons after hip fracture. Journal of affective disorders. vol 111. issue 1. 2008-12-11. PMID:18334271. |
polymorphisms of the serotonin 1a (5htr1a) and 2a receptors (5htr2a) are associated with depression; therefore, we examined their association with depressive symptoms and functional recovery after hip fracture. |
2008-12-11 |
2023-08-12 |
Not clear |
| Lena C Quilty, Liesel-Ann C Meusel, R Michael Bagb. Neuroticism as a mediator of treatment response to SSRIs in major depressive disorder. Journal of affective disorders. vol 111. issue 1. 2008-12-11. PMID:18384882. |
in the current investigation, we examined the hypothesis that any change in depression severity is mediated through the reduction of neuroticism, but only for those compounds which target serotonin receptors. |
2008-12-11 |
2023-08-12 |
Not clear |
| George W Brown, Tirril O Harri. Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interaction. Journal of affective disorders. vol 111. issue 1. 2008-12-11. PMID:18534686. |
depression and the serotonin transporter 5-httlpr polymorphism: a review and a hypothesis concerning gene-environment interaction. |
2008-12-11 |
2023-08-12 |
Not clear |
| George W Brown, Tirril O Harri. Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interaction. Journal of affective disorders. vol 111. issue 1. 2008-12-11. PMID:18534686. |
studies of the interaction of the serotonin transporter genotype and environment upon adult depression (g x e) have suggested a role for both childhood maltreatment and stressful life events. |
2008-12-11 |
2023-08-12 |
Not clear |
| N D Demchuk, A A Shuto. [Correction of motor and affective symptoms of parkinsonism by selective serotonine reuptake inhibition antidepressant]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 108. issue 9. 2008-12-11. PMID:18833168. |
the levels of motor disability, anxiety, depression and serum serotonin (s) concentration were measured. |
2008-12-11 |
2023-08-12 |
Not clear |
| Giampietro Frison, Donata Favretto, Susanna Vogliardi, Claudio Terranova, Santo Davide Ferrar. Quantification of citalopram or escitalopram and their demethylated metabolites in neonatal hair samples by liquid chromatography-tandem mass spectrometry. Therapeutic drug monitoring. vol 30. issue 4. 2008-12-08. PMID:18641554. |
citalopram and escitalopram are highly selective serotonin reuptake inhibitors widely used in the treatment of depression. |
2008-12-08 |
2023-08-12 |
Not clear |
| Karim A Alkadhi, Reem S Al-Hijailan, Karem H Alzoub. Long-term depression in the superior cervical ganglion of the rat. Brain research. vol 1234. 2008-12-08. PMID:18718451. |
treatment of ganglia with the 5-ht(3) receptor antagonist mdl 72222 (0.5 microm) during the maintenance phase of established gltd (1 h after lfs) antagonized the lfs-induced depression. |
2008-12-08 |
2023-08-12 |
rat |
| Gil Klinger, Paul Merlo. Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. The Israel journal of psychiatry and related sciences. vol 45. issue 2. 2008-12-04. PMID:18982836. |
selective serotonin reuptake inhibitors (ssris) are increasingly being used to treat depression prior to and throughout pregnancy. |
2008-12-04 |
2023-08-12 |
Not clear |
| A Vanoli, C J Lane, Claire Harrison, N I Steen, A H Youn. Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications. Journal of psychopharmacology (Oxford, England). vol 22. issue 4. 2008-12-03. PMID:18635723. |
venlafaxine, a dual serotonin and noradrenaline re-uptake inhibitor, has been found to be effective at doses below 375 mg daily, but for patients with major depression higher doses can be required. |
2008-12-03 |
2023-08-12 |
Not clear |
| Peter L Tenor. Psychotherapeutic benefits of opioid agonist therapy. Journal of addictive diseases. vol 27. issue 3. 2008-12-03. PMID:18956529. |
the most recent neurotransmitter theories on the origin of depression and anxiety will be reviewed, including current information on the role of serotonin, n-methyl d-aspartate, glutamate, cortisol, catecholamine, and dopamine in psychiatric disorders. |
2008-12-03 |
2023-08-12 |
Not clear |
| Trudie C Somberg, Rohit R Aror. Depression and heart disease: therapeutic implications. Cardiology. vol 111. issue 2. 2008-11-26. PMID:18376116. |
we reviewed possible explanations for this increased morbidity, which include: toxicity of tricyclic antidepressants that can cause cardiac arrhythmias, abnormalities in platelet function leading to increased platelet aggregation due to abnormalities in serotonin in the platelet (an abnormality that possibly causes depression in the central nervous system), diffuse atherosclerosis causing central nervous system abnormalities including depression (vascular depression), as well as the possibility that depressed patients are less compliant with their medications and physician-directed health recommendations. |
2008-11-26 |
2023-08-12 |
Not clear |
| Ibrahim Guner, Gulderen Sahin, Nermin Karaturan Yelmen, Ugur Aksu, Tulin Oruc, Zeynep Yildiri. Intracerebroventricular serotonin reduces the degree of acute hypoxic ventilatory depression in peripherally chemodenervated rabbits. The Chinese journal of physiology. vol 51. issue 3. 2008-11-25. PMID:18935908. |
intracerebroventricular serotonin reduces the degree of acute hypoxic ventilatory depression in peripherally chemodenervated rabbits. |
2008-11-25 |
2023-08-12 |
Not clear |
| Ibrahim Guner, Gulderen Sahin, Nermin Karaturan Yelmen, Ugur Aksu, Tulin Oruc, Zeynep Yildiri. Intracerebroventricular serotonin reduces the degree of acute hypoxic ventilatory depression in peripherally chemodenervated rabbits. The Chinese journal of physiology. vol 51. issue 3. 2008-11-25. PMID:18935908. |
the accumulation of serotonin (5-ht) in the central nervous system might cause hypoxic respiratory depression. |
2008-11-25 |
2023-08-12 |
Not clear |